Toward the development of an antidisease, transmission-blocking intranasal vaccine for group A streptococcus

Journal of Infectious Diseases

Volumn 192, Issue 8, 2005, Pages 1450-1455

  Batzloff, Michael R ^a   Yan, Huaru ^a   Davies, Mark R ^a   Hartas, Jon ^a   Lowell, George H ^b   White, Gregory ^b   Burt, David S ^b   Leanderson, Tomas ^c   Good, Michael F ^a,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ID Biomedical Corp of Quebec   (Canada)

^c Active Biotech Research AB   (Sweden)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; J14 PEPTIDE; M PROTEIN; OUTER MEMBRANE PROTEIN; PEPTIDE DERIVATIVE; PROTEOSOME; STREPTOCOCCUS VACCINE; TUBERCULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLOOD SAMPLING; CELL ASSAY; CONTROLLED STUDY; DRUG FORMULATION; DRUG SAFETY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INOCULATION; LYMPH NODE CELL; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROVOCATION TEST; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SURVIVAL RATE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; DISEASE TRANSMISSION; EPITOPES, B-LYMPHOCYTE; FECES; IMMUNOGLOBULIN G; MICE; NASAL MUCOSA; SALIVA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 25844439394     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/466528     Document Type: Article

References (15)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
2. Brandt ER, Hayman WA, Currie B, et al. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Int Immunol 1999; 11:569-76.
3. D'Alessandri R, Plotkin G, Kluge RM, et al. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with type 3 or type 12 group A streptococcus. J Infect Dis 1978; 138:712-8.
4. Bessen D, Fischetti VA. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med 1988; 167:1945-50.
5. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 1997; 9:1723-33.
6. Lowell G, Burt DS, White GL, Fries LF. Proteosome™ technology for vaccines and adjuvants. In: Levine MM, Kaper JB, Rappuoli R, Liu A, Good MF, eds. New generation vaccines. 3rd ed. New York: Marcel Dekker, 2004:271-82.
7. Pruksakorn S, Galbraith A, Houghten RA, Good MF. Conserved T and B cell epitopes on the M protein of group A streptococci: induction of bactericidal antibodies. J Immunol 1992; 149:2729-35.
8. Brandt ER, Hayman WA, Currie B, et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1996; 89:331-7.
9. Brandt ER, Hayman WA, Currie B, Pruksakorn S, Good MF. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Vaccine 1997; 15:1805-12.
10. Flores AE, Johnson DR, Kaplan EL, Wannamaker LW. Factors influencing antibody responses to streptococcal M proteins in humans. J Infect Dis 1983; 147:1-15.
11. Beachey EH, Cunningham M. Type-specific inhibition of preopsonization versus immunoprecipitation by streptococcal M proteins. Infect Immun 1973; 8:19-24.
12. Johnson DR, Kaplan EL, Sramek J, et al. Laboratory diagnosis of group A streptococcal infections. 1st ed. Geneva: World Health Organization, 1996.
13. Batzloff MR, Hayman WA, Davies MR, et al. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 2003; 187:1598-608.
14. Goodman-Snitkoff G, Good MF, Berzofsky JA, Mannino RJ. Role of intrastructural/intermolecular help in immunization with peptide-phospholipid complexes. J Immunol 1991; 147:410-5.
15. Bronze MS, McKinsey DS, Beachey EH, Dale JB. Protective immunity evoked by locally administered group A streptococcal vaccines in mice. J Immunol 1988; 141:2767-70.